AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
_6ff029a61766633234293.png?format=webp&width=1186&height=250)
Mesoblast's 15min chart shows KDJ Death Cross and Bearish Marubozu.
ByAinvest
Wednesday, Sep 10, 2025 12:17 pm ET2min read
Mesoblast's 15-minute chart has recently exhibited a KDJ Death Cross and a bearish Marubozu formation, as of September 10, 2025 at 12:15. This development indicates a shift in momentum towards the downside, suggesting a potential for further price decreases. The sellers currently dominate the market, and it is likely that bearish momentum will persist.
As of September 10, 2025, at 12:15, Mesoblast's 15-minute chart has exhibited a KDJ Death Cross and a bearish Marubozu formation [1]. These technical indicators suggest a significant shift in momentum towards the downside, potentially indicating further price decreases.The KDJ Death Cross occurs when the K line (fast stochastic) crosses below the D line (slow stochastic), signaling a potential downward trend [1]. The bearish Marubozu, characterized by a long body with no shadows above or below, indicates strong selling pressure [2]. These signals align with broader trends observed in other stocks, including narrowing Bollinger Bands and KDJ Death Cross formations [^1, 2].
While these technical indicators provide insights into potential stock price movements, investors should consider these signals in conjunction with fundamental analysis and broader market conditions. Positive analyst ratings and price targets for various stocks, including Mesoblast, offer valuable insights into the potential performance of these companies [1].
Positive Outlook:
- Alnylam Pharma (ALNY) received a "Buy" rating from Jefferies with a price target of $384.00 [1].
- Chime Financial (CHYM) was initiated with an "Overweight" rating by multiple firms, including Morgan Stanley and Barclays, with targets ranging from $39.00 to $40.00 [1].
- CryoPort (CYRX) was rated "Buy" by BTIG Research with a price target of $10.00 [1].
- Datadog (DDOG) had its price target raised from $150.00 to $175.00 by Bank of America, reiterating a "Buy" rating [1].
- Energy Transfer (ET) was initiated with a "Buy" rating by TD Cowen with a price target of $22.00 [1].
- Grab (GRAB) was rated "Buy" by Jefferies with a price target of $5.70, indicating a 20.94% upside [1].
- Home Depot (HD) was rated "Buy" by TD Cowen with a price target of $470.00 [1].
- Intuit (INTU) was rated "Buy" by Morgan Stanley with a price target of $900.00 [1].
- JPMorgan Chase & Co. (JPM) had a $298.00 target set by Evercore ISI with an "Outperform" rating [1].
- Kinder Morgan (KMI) was initiated with a "Buy" rating by TD Cowen [1].
- Lam Research (LRCX) had its "Buy" rating reiterated by Citigroup [1].
- MACOM Technology Solutions (MTSI) had its target raised from $136.00 to $154.00 by Truist Financial, maintaining a "Buy" rating [1].
- Monopar Therapeutics (MNPR) was initiated with an "Overweight" rating by Cantor Fitzgerald and a target of $74.00 [1].
- Norwegian Cruise Line (NCLH) received a "Buy" rating from Jefferies with a price target of $29.00 [1].
- Oracle (ORCL) received a "Buy" rating from UBS with a $250.00 target [1].
- Oportun Financial (OPRT) was rated "Buy" at B. Riley Financial with an $11.00 price target [1].
- Ovintiv (OVV) was rated "Buy" at Barclays Capital with a price target of $55.00 [1].
- Phibro Animal Health (PAHC) was upgraded at JPMorgan Chase from Neutral to Overweight, with the price target raised from $25.00 to $35.00 [1].
- Progressive (PGR) was downgraded by Morgan Stanley from Overweight to Equal Weight, with a price target of $290.00 [1].
- Pulse Biosciences (PLSE) was initiated by Oppenheimer with an "Outperform" rating and a $22.00 price target [1].
- PTC (PTC) had its Overweight rating reiterated by KeyCorp Bank [1].
- Rockwell Automation (ROK) was initiated by CICC Research with a "Buy" rating and a price target of $320.00 [1].
In conclusion, while Mesoblast's recent chart signals suggest a bearish trend, investors should consider these indicators alongside other factors and fundamental analysis to make informed investment decisions.
[1]: https://www.ainvest.com/news/mesabi-trust-kdj-death-cross-15min-chart-signals-bearish-marubozu-2508/
[2]: https://www.ainvest.com/news/stantec-15-minute-chart-sees-kdj-golden-cross-bullish-marubozu-formation-2508/
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet